respiratory
Public Health

New cancer drugs are very expensive – here’s how we work out value for our money


The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and ...

Already a member?

Enter your email to keep reading.


OR